Mirum Pharmaceuticals (MIRM) Inventory Average (2022 - 2026)

Mirum Pharmaceuticals' Inventory Average history runs 5 years deep, the most recent figure standing at $25.2 million for Q1 2026.

• In Q1 2026, Inventory Average rose 12.46% year-over-year to $25.2 million; the TTM figure through Mar 2026 stood at $25.2 million (up 12.46% YoY), while the FY2025 annual figure was $23.6 million, up 5.76% from the prior year.
• Inventory Average for Q1 2026 stood at $25.2 million, up from $24.5 million in the prior quarter.
• The five-year high for Inventory Average was $25.2 million in Q1 2026, with the low at $1.5 million in Q1 2022.
• The 5-year median for Inventory Average is $21.0 million (2024), against an average of $16.0 million.
• The sharpest annual moves came in 2023 and 2024: Inventory Average jumped 293.73% in 2023, then slipped 1.27% in 2024.
• Mirum Pharmaceuticals' Inventory Average stood at $6.3 million in 2022, then surged by 256.27% to $22.3 million in 2023, then declined by 1.27% to $22.0 million in 2024, then increased by 11.16% to $24.5 million in 2025, then gained by 3.06% to $25.2 million in 2026.
• Business Quant data shows MIRM's Inventory Average at $25.2 million in Q1 2026, $24.5 million in Q4 2025, and $23.5 million in Q3 2025.